أخبار السوق اليوم — عناوين الأسهم والعملات الرقمية المنتقاة بالذكاء الاصطناعي

مدعوم بـ 5 مزوّدي ذكاء اصطناعي + نظام احتياطي قائم على القواعد

Gemini Groq Mistral DeepSeek OpenAI نظام احتياطي قائم على القواعد
🤖 5 نماذج ذكاء اصطناعي + نظام احتياطي ⚡ آني 📊 تحليل المشاعر
عرض أخبار HIMS العودة إلى HIMS
مسح المرشح

🧭 ملخص السوق اليومي (مايو. 29, 2026) 🤖 مدعوم بالذكاء الاصطناعي

Analysis of Bitcoin market analysis, stock market developments showing bullish sentiment.

Trending Evidence Watch

High-confidence AI observations with source context and evaluated outcome tracking

No High-Impact Observations

No major high-confidence observations detected at this time.

تحقق قريبًا أو تصفح آخر الأخبار أدناه للاطلاع على القصص المتطورة.

آخر الأخبار (13 مقالات)

Economy Yahoo Finance 80% GROQ-LLAMA-3.3-70B-VERSATILE
25d ago
S&P 500, Nasdaq end lower as inflation, Iran tensions weigh

STORY: U.S. stocks ended mostly lower on Tuesday, but the Dow posted a modest gain, while the S&P 500 edged …

The S&P 500 and Nasdaq declined due to higher-than-expected inflation and ongoing Iran tensions, while … الأعلى (80%)
عرض التحليل الكامل →
Stocks CNBC 60% FREE-ANALYSIS-RULE-BASED-ANALYSIS
25d ago
Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance

Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on …

Financial market analysis indicating bearish sentiment based on current trends. متوسط (60%)
عرض التحليل الكامل →
Economy Bloomberg 60% FREE-ANALYSIS-RULE-BASED-ANALYSIS
26d ago
Hims Sales Miss on Rising Competition for Weight-Loss Drugs

Hims & Hers Health Inc. reported a first-quarter loss and sales that missed Wall Street estimates amid increasing competition in …

Financial market analysis indicating bearish sentiment based on current trends. متوسط (60%)
عرض التحليل الكامل →
Economy Yahoo Finance 50% FREE-ANALYSIS-RULE-BASED-ANALYSIS
26d ago
Earnings live updates: Plug Power, Hims & Hers set to kick off week of quarterly updates

The pace of first quarter earnings reports eases this week as economic data takes center stage, but investors will still …

Financial market analysis indicating neutral sentiment based on current trends. متوسط (50%)
عرض التحليل الكامل →
Economy Yahoo Finance 94% HUGGINGFACE-PROSUSAI/FINBERT
44d ago
Hims Yields Ground in GLP-1 Market. Why Its CEO Is Calling It the Netflix of Pharma.

Hims & Hers Health will allow providers to prescribe scripts filled by LillyDirect, Eli Lilly’s direct-to-consumer platform.

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. الأعلى (94%)
عرض التحليل الكامل →
Economy Yahoo Finance 94% HUGGINGFACE-PROSUSAI/FINBERT
46d ago
Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program

Telehealth investors weigh Amazon’s new anti-obesity drug push against this platform’s recent rapid growth, today, April 21, 2026.

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. الأعلى (94%)
عرض التحليل الكامل →
Economy Yahoo Finance 94% HUGGINGFACE-PROSUSAI/FINBERT
50d ago
Here’s How Cedar Grove Capital Management Benefitted from Its Short Position in Hims & Hers Health (HIMS)

Michigan-based investment advisor Cedar Grove Capital Management recently released its first quarter 2026 investor letter. A copy of the letter …

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. الأعلى (94%)
عرض التحليل الكامل →
Economy Yahoo Finance 94% HUGGINGFACE-PROSUSAI/FINBERT
51d ago
Stock Market Today, April 16: Hims & Hers Health Jumps on FDA Review of Compounded Peptide Therapies

On April 16, 2026, investors monitored an FDA peptide review that could be a boost to Hims & Hers Health.

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. الأعلى (94%)
عرض التحليل الكامل →
Stocks CNBC 94% HUGGINGFACE-PROSUSAI/FINBERT
51d ago
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves

Hims may have an chance to grow peptides business as a potential revenue driver, with FDA review in 2026 shaping …

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. الأعلى (94%)
عرض التحليل الكامل →
Economy Yahoo Finance 94% HUGGINGFACE-PROSUSAI/FINBERT
51d ago
Hims stock gains as FDA reviews peptides, Voyager secures NASA contract

Market Catalysts Host Julie Hyman and Yahoo Finance Senior Reporter Brooke DiPalma track several of the day's top trending stock …

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. الأعلى (94%)
عرض التحليل الكامل →
Economy Bloomberg 94% HUGGINGFACE-PROSUSAI/FINBERT
51d ago
US Premarket Movers: Hims & Hers, PPG Industries, QuidelOrtho

S&P 500 Index futures rise 0.1% as of 7:51 a.m. in New York as an upbeat forecast from TSMC lifts …

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. الأعلى (94%)
عرض التحليل الكامل →
Stocks MarketWatch 94% HUGGINGFACE-PROSUSAI/FINBERT
52d ago
Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides

Hims & Hers Health’s plan to enter the business of selling peptides is looking a lot more realistic.

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. الأعلى (94%)
عرض التحليل الكامل →

لا توجد مقالات تطابق مرشحاتك.

احصل على معلومات السوق يومياً

أخبار وتحليلات منتقاة بالذكاء الاصطناعي — مجاناً، مباشرةً إلى بريدك الإلكتروني.

🤖

رؤية السوق

تحليل متعدد المزودين بالذكاء الاصطناعي

محايد

ملخص الذكاء الاصطناعي

جاري التحميل...

الثقة
جاري التحليل...
نموذج الذكاء الاصطناعي الذكاء الاصطناعي متعدد المزودين